# Open Label Study of Ceftobiprole to Evaluate Pharmacokinetics in Adults Hospitalized in the ICU

> **NCT00770978** · PHASE1 · COMPLETED · sponsor: **Basilea Pharmaceutica** · enrollment: 33 (actual)

## Conditions studied

- ICU

## Interventions

- **DRUG:** ceftobiprole q12h
- **DRUG:** ceftobiprole q8h

## Key facts

- **NCT ID:** NCT00770978
- **Lead sponsor:** Basilea Pharmaceutica
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2012-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00770978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00770978, "Open Label Study of Ceftobiprole to Evaluate Pharmacokinetics in Adults Hospitalized in the ICU". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00770978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*